HOB Biotech Group Corp.,Ltd

Equities

688656

CNE100004C37

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
24.96 CNY -1.34% Intraday chart for HOB Biotech Group Corp.,Ltd +0.04% -28.19%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares. CI
HOB Biotech Group Corp.,Ltd authorizes a Buyback Plan. CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2024. CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
HOB Biotech Inks Deal With Spain’s Inmunotek to Distribute Allergy Treatment in China MT
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021 CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange Composite Index CI
HOB Biotech Group Corp.,Ltd(SHSE:688656) added to Shanghai Stock Exchange A Share Index CI
Certain A Shares of HOB Biotech Group Corp., Ltd are subject to a Lock-Up Agreement Ending on 14-JAN-2022. CI
HOB Biotech Group Corp.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Hob Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
HOB Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 CI
HOB Biotech : Surges 112% in Shanghai Trading Debut MT
Hob Biotech Group Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2019 CI
HOB Biotech Group Corp., Ltd has completed an IPO in the amount of CNY 555.859161 million. CI
HOB Biotech Group Corp., Ltd has filed an IPO. CI
Chart HOB Biotech Group Corp.,Ltd
More charts
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company provides two categories of products: allergy testing products and self-immune testing products. Its detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others. The Company conducts its businesses in the domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 688656 Stock
  4. News HOB Biotech Group Corp.,Ltd
  5. HOB Biotech Inks Deal With Spain’s Inmunotek to Distribute Allergy Treatment in China